Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Peer review of the pesticide risk assessment of the active substance flurochloridone.

EFSA journal. European Food Safety Authority·2026

Same author

Immunosuppression after pediatric liver transplantation may lead to early and prolonged acute thymic involution: findings from a pilot longitudinal study.

Frontiers in immunology·2026

Same author

Peer review of the pesticide risk assessment of the active substance <i>Bacillus paralicheniformis</i> strain FMCH001.

EFSA journal. European Food Safety Authority·2026

Same author

Peer review of the pesticide risk assessment of the active substance <i>Bacillus subtilis</i> strain FMCH002.

EFSA journal. European Food Safety Authority·2026

Same author

Peer review of the pesticide risk assessment of the active substance cymoxanil.

EFSA journal. European Food Safety Authority·2026

Same author

Peer review of the pesticide risk assessment for the active substance bifenazate in light of confirmatory data submitted.

EFSA journal. European Food Safety Authority·2026

Search research articles

Related Experiment Video

Updated: Aug 25, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Type 2 autoimmune hepatitis: Genetic susceptibility.

Pascal Lapierre^1,2, Fernando Alvarez^3,4

¹Laboratoire d'hépatologie cellulaire, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.

Frontiers in Immunology

|October 17, 2022

Summary

Autoimmune hepatitis type 2 (AIH-2) involves specific autoantibodies targeting liver-specific antigens, often diagnosed in children. Genetic factors and environmental triggers likely influence AIH-2 development.

Keywords:

HLA MHC autoimmunity genetic liver

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Aug 25, 2025

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

Immunology
Hepatology
Genetics

Background:

Autoimmune hepatitis (AIH) presents as AIH-1 and AIH-2, distinguished by autoantibody profiles and targeted autoantigens.
AIH-2 autoantibodies target cytochrome P450 2D6 (anti-LKM1) and Formiminotransferase-cyclodeaminase (anti-LC1), which are predominantly expressed in hepatocytes.

Purpose of the Study:

To differentiate the immunological and clinical characteristics of AIH-2 from AIH-1.
To explore the genetic associations and potential triggers for AIH-2.

Main Methods:

Comparative analysis of autoantibody profiles (anti-nuclear, anti-smooth muscle, anti-LKM1, anti-LC1).
Clinical feature assessment including age of diagnosis, disease onset, and associated conditions.
Human Leukocyte Antigen (HLA) class II allele association studies.

Main Results:

AIH-2 is characterized by anti-LKM1 and/or anti-LC1 antibodies, targeting tissue-specific autoantigens.
AIH-2 exhibits distinct clinical features: earlier onset (mean age 6.6 years), higher frequency in children, fulminant hepatitis in young children, and association with primary immunodeficiency and extrahepatic autoimmune diseases.
Specific HLA class II alleles, particularly DQB1*0201, are strongly associated with AIH-2 susceptibility.

Conclusions:

AIH-2 is immunologically distinct due to its specific autoantigens and genetic predisposition.
Genetic factors, particularly HLA alleles, play a significant role in AIH-2 pathogenesis, likely interacting with environmental triggers.